Human papillomavirus type 16 E2 and E6/E7 variants

被引:32
作者
Swan, DC [1 ]
Rajeevan, M
Tortolero-Luna, G
Follen, M
Tucker, RA
Unger, ER
机构
[1] Ctr Dis Control & Prevent, US Dept HHS, Natl Ctr Infect Dis, Publ Hlth Serv, Atlanta, GA 30333 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA
关键词
HPV16; variants; E6; E7; E2; cervical disease;
D O I
10.1016/j.ygyno.2004.11.045
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. Polymorphisms in human papillomavirus (HPV) type 16 have been shown to be related to geographic areas and are broadly classified as European (E), African (At), Asian (As), or Asian-American (AA). Certain variants have been reported as being more likely to cause cervical disease; our objectives were to identify new HPV16 polymorphisms, to determine the linkage of the E2 and E6/E7 regions and to determine the minimum sequence necessary to classify variants. Methods. We sequenced the complete E2, E6, and E7 regions in all HPV16-positive cervical samples identified in a case-control study of pre-invasive cervical disease. Results. In the 100 samples analyzed, only one new polymorphism was identified, a synonymous change, T3205A, in region E2. The frequency distribution of variants in the sample set was 37 European prototypes and 27 E-G350, 16 AA, 5 Af1, 2 Af2, 8 E-C109G, 3 E-G131G, and 2 As. As shown by others, region E7 varied much less than E6 and E2. Conclusions. In each case, E2 changes were linked to the expected E6/E7 changes, and there was no evidence for recombination. The linkage between E2 and E6/E7 allows variant classification to be based on a short E6 sequence (nt 109-350). (c) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:695 / 700
页数:6
相关论文
共 29 条
[1]   IDENTIFICATION AND ASSESSMENT OF KNOWN AND NOVEL HUMAN PAPILLOMAVIRUSES BY POLYMERASE CHAIN-REACTION AMPLIFICATION, RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS, NUCLEOTIDE-SEQUENCE, AND PHYLOGENETIC ALGORITHMS [J].
BERNARD, HU ;
CHAN, SY ;
MANOS, MM ;
ONG, CK ;
VILLA, LL ;
DELIUS, H ;
PEYTON, CL ;
BAUER, HM ;
WHEELER, CM .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) :1077-1085
[2]  
Bontkes HJ, 1998, INT J CANCER, V78, P166, DOI 10.1002/(SICI)1097-0215(19981005)78:2<166::AID-IJC8>3.0.CO
[3]  
2-X
[4]  
Casas L, 1999, INT J CANCER, V83, P449, DOI 10.1002/(SICI)1097-0215(19991112)83:4&lt
[5]  
449::AID-IJC3&gt
[6]  
3.0.CO
[7]  
2-0
[8]   MOLECULAR VARIANTS OF HUMAN PAPILLOMAVIRUS TYPE-16 FROM 4 CONTINENTS SUGGEST ANCIENT PANDEMIC SPREAD OF THE VIRUS AND ITS COEVOLUTION WITH HUMANKIND [J].
CHAN, SY ;
HO, L ;
ONG, CK ;
CHOW, V ;
DRESCHER, B ;
DURST, M ;
TERMEULEN, J ;
VILLA, L ;
LUANDE, J ;
MGAYA, HN ;
BERNARD, HU .
JOURNAL OF VIROLOGY, 1992, 66 (04) :2057-2066
[9]   THE ASSOCIATION OF AN HPV16 ONCOGENE VARIANT WITH HLA-B7 HAS IMPLICATIONS FOR VACCINE DESIGN IN CERVICAL-CANCER [J].
ELLIS, JRM ;
KEATING, PJ ;
BAIRD, J ;
HOUNSELL, EF ;
RENOUF, DV ;
ROWE, M ;
HOPKINS, D ;
DUGGANKEEN, MF ;
BARTHOLOMEW, JS ;
YOUNG, LS ;
STERN, PL .
NATURE MEDICINE, 1995, 1 (05) :464-470
[10]   Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region [J].
Eriksson, A ;
Herron, JR ;
Yamada, T ;
Wheeler, CM .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :595-600